pride, prejudice and... prep
DESCRIPTION
Appraising the impact of new prevention technologies. This presentation was given by Dean Murphy (AFAO) at the AFAO HIV Educators Conference 2010.TRANSCRIPT
Australian Federation of AIDS Organisations
Pride, prejudice and... PrEPPride, prejudice and... PrEP: : appraising the impact of new appraising the impact of new
prevention technologiesprevention technologies
Dean MurphyDean Murphy
AFAO HIV Educators’ Conference 2010AFAO HIV Educators’ Conference 2010
BackgroundBackground
• By the end of 2010, results of some clinical trials By the end of 2010, results of some clinical trials of HIV pre-exposure prophylaxis (PrEP) will be of HIV pre-exposure prophylaxis (PrEP) will be released.released.
• This presentation: This presentation: – PrEP trialsPrEP trials– HIV-related stigma and discriminationHIV-related stigma and discrimination– Possible impacts of PrEP Possible impacts of PrEP
Current PrEP trials: whenCurrent PrEP trials: when
Current PrEP trials: what; whoCurrent PrEP trials: what; who
Current PrEP trials: whereCurrent PrEP trials: where
Expectations
• We don’t know much about expectations of PrEP among gay men & MSM
• PrEP study by MSM Global Forum is starting now
• In US, low levels of awareness of PrEP among gay and bisexual men, and very low levels of non-prescribed use
• However, high acceptability if efficacious
HIV-related stigma and HIV-related stigma and discriminationdiscrimination
• Experience of stigma associated with:– More social engagement with other PLHIV– Greater importance of own serostatus identity– [Not associated with having HIV-negative or status
unknown regular or casual partners]
• Expression of stigma associated with:– Less social engagement with PLHIV and gay men– More perceived HIV transmission risk– Greater importance of own serostatus identity– [Not associated with having HIV-positive regular or
casual partners]
PrEP and increased HIV-related stigma?
• Attitudes towards people who seroconvert in the post-PrEP era
• PrEP ‘failures’ (i.e. viral breakthrough)• Disclosure (e.g. for seroodiscordant couples)• Responsibility/criminalisation• Access• Designation of new risk groups (who are
recommended for PrEP)• Resources
PrEP and decreased HIV-related stigma?
• Reduced HIV transmission risk • More serodiscordant relationships• Less stigmatising attitude towards HIV in general • Serostatus identity?• Re-engagement with HIV prevention
• New risk reduction strategies?
Keeping up to date…Keeping up to date…
• AIDS Vaccine Advocacy Coalition (AVAC)AIDS Vaccine Advocacy Coalition (AVAC)– http://www.avac.org (This site has replaced prepwatch.org)http://www.avac.org (This site has replaced prepwatch.org)
• Community HIV/AIDS Mobilization Project (CHAMP)Community HIV/AIDS Mobilization Project (CHAMP)– http://www.champnetwork.org/iprep-research-agendahttp://www.champnetwork.org/iprep-research-agenda
• AFAOAFAO– http://www.afao.org.au/http://www.afao.org.au/
• National Institutes of HealthNational Institutes of Health– http://clinicaltrials.gov/